Silence Therapeutics's total assets for Q3 2024 were £169.38M, a decrease of -10.21% from the previous quarter. SLN total liabilities were £74.87M for the fiscal quarter, a -1.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.